Jump to navigation Jump to search

Template:Chembox new

WikiDoc Resources for Irofulven


Most recent articles on Irofulven

Most cited articles on Irofulven

Review articles on Irofulven

Articles on Irofulven in N Eng J Med, Lancet, BMJ


Powerpoint slides on Irofulven

Images of Irofulven

Photos of Irofulven

Podcasts & MP3s on Irofulven

Videos on Irofulven

Evidence Based Medicine

Cochrane Collaboration on Irofulven

Bandolier on Irofulven

TRIP on Irofulven

Clinical Trials

Ongoing Trials on Irofulven at Clinical

Trial results on Irofulven

Clinical Trials on Irofulven at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Irofulven

NICE Guidance on Irofulven


FDA on Irofulven

CDC on Irofulven


Books on Irofulven


Irofulven in the news

Be alerted to news on Irofulven

News trends on Irofulven


Blogs on Irofulven


Definitions of Irofulven

Patient Resources / Community

Patient resources on Irofulven

Discussion groups on Irofulven

Patient Handouts on Irofulven

Directions to Hospitals Treating Irofulven

Risk calculators and risk factors for Irofulven

Healthcare Provider Resources

Symptoms of Irofulven

Causes & Risk Factors for Irofulven

Diagnostic studies for Irofulven

Treatment of Irofulven

Continuing Medical Education (CME)

CME Programs on Irofulven


Irofulven en Espanol

Irofulven en Francais


Irofulven in the Marketplace

Patents on Irofulven

Experimental / Informatics

List of terms related to Irofulven


Irofulven or 6-hydroxymethylacylfulvene (also known as HMAF of MGI-114) is a substance that is used in the treatment of cancer. It belongs to the family of drugs called alkylating agents.

Irofulven is an analogue of illudin S, a sesquiterpene toxin found in mushrooms of the genus Omphalotus. The compound was oringally synthesized by Dr. Trevor McMorris (UCSD) and found to have anticancer properties by Dr. Michael J Kelner (UCSD).[1]


Kelner MJ, McMorris TC, Estes L, Wang W, Samson KM, Taetle R. Efficacy of HMAF (MGI-114) in the MV522 metastatic lung carcinoma xenograft model nonresponsive to traditional anticancer agents. Invest New Drugs 14(2) 161-167, 1996 Template:WH Template:WikiDoc Sources

  1. MacDonald JR, Muscoplat CC, Dexter DL, Mangold GL, Chen SF, Kelner MJ, McMorris TC, Von Hoff DD (1997). "Preclinical antitumor activity of 6-hydroxymethylacylfulvene, a semisynthetic derivative of the mushroom toxin illudin S". Cancer Res. 57 (2): 279–83. PMID 9000568. Free full text